Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Tiotropium in Renal Impairment
NCT02172339Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 1998
- Primary completion
- Dec 1998
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the curve (0-4h), Renal clearance at Day 25 and 2 more. Started Apr 1998; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02172339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02172339.